Clinical TrialsSearch results
Number of results: 832
Recruiting
- A single-arm trial of daprodustat for low-risk myelodysplastic syndromes
- Myelodysplastic syndromes
- Kunimoto Hiroyoshi
- 2024-05-13
Recruiting
- A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study (UmbrellaMAX)
- Cancer
- Timothy Eisen
- 2023-08-04
Recruiting
- A Randomized Prospective Study on Age-related Changes in Peri-Stem Femoral Bone Mineral Density and Bone Morphology of Curved-Short Stems and Fully Hydroxyapatite-Coated Stems in Total Hip Arthroplasty
- osteoarthritis of the hip
- Hirakawa Kazuo
- 2023-11-19
Recruiting
- A randomized controlled trial of treatments for ISSNHL and ALHL
- idiopathetic sudden sensorineuronal hearing loss and acute low-tone sensorineural hearing loss
- Hyakusoku Hiroshi
- 2022-03-26
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01
Recruiting
- A Prospective Cohort Multi-Institutional Observational Study of the Gut Microbiota in Gastroenterological Cancer
- Gastrointestinal cancer
- Endo Itaru
- 2022-08-02
Recruiting
- A Platform Trial of Optimal Treatment for Pneumonia including (Re-)Emerging Infections
- Community-acquired pneumonia and COVID-19 infection
- Fujitani Shigeki
- 2021-06-14
Recruiting
- A pilot study to evaluate AMPA receptors densities in striatum with [11C]K-2 PET imaging in Parkinson's disease.
- Parkinson's disease
- Abe Hiroki
- 2021-03-29
Recruiting
- A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-Center Study to Evaluate the Efficacy and Safety of nemolizumab in Japanese Infant and Pediatric Atopic Dermatitis Patients with moderate to severe pruritus
- Pruritus of atopic dermatitis which is inadequately controlled by the currently available therapy
- Nishiura Tomoyuki
- 2023-06-25
Recruiting
- A Phase III, Randomised, Open-label, Multicentre, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab and Carboplatin Versus Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Locally Advanced or Metastatic NSCLC Without Actionable Genomic Alterations (D926NC00001; AVANZAR)
- NSCLC
- Hibi Kazushige
- 2023-02-06